PCSK9 plasma levels have been associated with obstructive coronary lesions in patients with acute coronary syndrome and myocardial infarction [6–10] as well as with subclinical coronary atherosclerosis and imaging markers of atherosclerotic risk even if in some reports this relationship is not so clear [11–18]. This evidence concerns the gene PCSK9 and myocardial infarction.